Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Italy relaunches HIV R&D programme

This article was originally published in Clinica

Executive Summary

The Italian health ministry has relaunched its HIV/AIDS R&D programme, backed by funding of €9.8m ($13.7m) to the end of 2010. The main aims of the two-year programme, which builds on its 2006-08 predecessor, are to boost biomedical research, improve the network of HIV care centres and strengthen institutional links. It places strong emphasis on the development of "diagnostic technologies used to optimise therapy", such as markers for predicting and assessing responses and side-effects.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043814

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel